These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23383310)

  • 1. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.
    Watzlawik JO; Warrington AE; Rodriguez M
    PLoS One; 2013; 8(2):e55149. PubMed ID: 23383310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes.
    Watzlawik J; Holicky E; Edberg DD; Marks DL; Warrington AE; Wright BR; Pagano RE; Rodriguez M
    Glia; 2010 Nov; 58(15):1782-93. PubMed ID: 20645409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures.
    Grassi S; Giussani P; Prioni S; Button D; Cao J; Hakimi I; Sarmiere P; Srinivas M; Cabitta L; Sonnino S; Prinetti A
    Neurochem Res; 2019 Jun; 44(6):1460-1474. PubMed ID: 30569280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia.
    Zorina Y; Stricker J; Caggiano AO; Button DC
    Sci Rep; 2018 Jun; 8(1):9392. PubMed ID: 29925848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination.
    Stangel M; Bernard D
    J Neuroimmunol; 2003 May; 138(1-2):25-30. PubMed ID: 12742649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
    Williams JL; Patel JR; Daniels BP; Klein RS
    J Exp Med; 2014 May; 211(5):791-9. PubMed ID: 24733828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
    Patel JR; Williams JL; Muccigrosso MM; Liu L; Sun T; Rubin JB; Klein RS
    Acta Neuropathol; 2012 Dec; 124(6):847-60. PubMed ID: 22933014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant human IgM promotes myelin repair after a single, very low dose.
    Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M
    J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
    Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
    J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
    Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
    Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method of identifying natural antibodies for remyelination.
    Warrington AE; Rodriguez M
    J Clin Immunol; 2010 May; 30 Suppl 1(0 1):S50-5. PubMed ID: 20387101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
    Cui QL; Kuhlmann T; Miron VE; Leong SY; Fang J; Gris P; Kennedy TE; Almazan G; Antel J
    Am J Pathol; 2013 Aug; 183(2):516-25. PubMed ID: 23746653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.
    Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C
    Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Tepavčević V; Lubetzki C
    Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental stage of oligodendrocytes determines their response to activated microglia in vitro.
    Miller BA; Crum JM; Tovar CA; Ferguson AR; Bresnahan JC; Beattie MS
    J Neuroinflammation; 2007 Nov; 4():28. PubMed ID: 18039385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination.
    Cui C; Wang J; Mullin AP; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Brain Res; 2018 Sep; 1694():73-86. PubMed ID: 29775564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor.
    Garwood J; Garcion E; Dobbertin A; Heck N; Calco V; ffrench-Constant C; Faissner A
    Eur J Neurosci; 2004 Nov; 20(10):2524-40. PubMed ID: 15548197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
    Xiao L; Guo D; Hu C; Shen W; Shan L; Li C; Liu X; Yang W; Zhang W; He C
    Glia; 2012 Jul; 60(7):1037-52. PubMed ID: 22461009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials.
    Sutiwisesak R; Burns TC; Rodriguez M; Warrington AE
    Expert Opin Investig Drugs; 2021 Aug; 30(8):857-876. PubMed ID: 34126015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.